“Buy Now, Pay Later” Is Taking Over Coachella (and DoorDash)
60% of attendees used “Buy Now, Pay Later” to afford Coachella 2025 — and it’s getting harder to tell...
Welcome to the Trending News section of Finblog.com, where we bring you only the most impactful and carefully selected news stories from the financial world. Our team of experts meticulously curates each article to ensure you receive the most relevant and significant updates that truly matter.
Ford Halts Shipments of F-150s and Other Models to China
Ford Motor Company has suspended shipments of several U.S.-built vehicles to China in response to retaliatory tariffs that have...
Why are more rich Americans opening Swiss bank accounts recently?
With U.S. political and economic tensions rising, wealthy Americans are once again shifting capital overseas—and Swiss banks are reaping...
Gold Is at a Record High. Why It Could Climb Even Higher?
Central banks are loading up on Gold as the dollar weakens — and Goldman says $3,700 is in sight....
Katy Perry’s Blue Origin space mess shows the world is fed up with entitled celebs who think they are owed adoration
All-female Blue Origin trip aimed for empowerment — landed in backlash. Three days after Katy Perry and an all-women...
Judge Rules Google Held Monopoly Over Online Ad Tech
Antitrust breakthrough: Google found to have illegally dominated digital advertising market. A federal judge ruled Thursday that Google illegally...
Trump Targets Powell: “Termination Can’t Come Soon Enough”
Markets shook after Fed Chair Jerome Powell warned Trump’s new tariffs would likely trigger “even higher inflation and slower...
The Tactics Elon Musk Uses to Manage His ‘Legion’ of Babies—and Their Mothers
Elon Musk, CEO of Tesla and SpaceX, has been reported to have fathered at least 14 children with multiple...
Nvidia’s CEO makes surprise visit to Beijing after US restricts chip sales to China
“China is a very important market for Nvidia, and we hope to continue to cooperate.” — Jensen Huang, in...
Eli Lilly’s Obesity Pill Hits Key Targets, Boosts Weight Loss in Type 2 Diabetes Trial
A needle-free alternative is on the way. Eli Lilly’s daily obesity pill, orforglipron, met key goals in a major...